We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+38.97%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$670M
AUM Growth
+$90.6M
Cap. Flow
-$42.2M
Cap. Flow %
-6.3%
Top 10 Hldgs %
36.6%
Holding
80
New
17
Increased
16
Reduced
32
Closed
15

Top Buys

Rank Stock Value
1
APRE icon
Aprea Therapeutics
APRE
+$40.5M
2
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$14.7M
3
BSX icon
Boston Scientific
BSX
+$12.4M
4
TFX icon
Teleflex
TFX
+$10M
5
CSII
Cardiovascular Systems, Inc.
CSII
+$9.37M

Top Sells

Rank Stock Value
1
WMGI
Wright Medical Group Inc
WMGI
+$21.9M
2
TDOC icon
Teladoc Health
TDOC
+$17.3M
3
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$17.2M
4
APLS
Apellis Pharmaceuticals
APLS
+$15M
5
NVS icon
Novartis
NVS
+$12.8M

Sector Composition

Rank Sector Weight
1 Healthcare 80.45%
2 Industrials 5.08%
3 Technology 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APRE icon
1
Aprea Therapeutics
APRE
$8.54M
$67.5M 10.07%
+73,517
New +$40.5M
TDOC icon
2
Teladoc Health
TDOC
$1.73B
$25M 3.73%
298,692
-226,819
-43% -$17.3M
BSX icon
3
Boston Scientific
BSX
$65.5B
$23.4M 3.5%
518,376
+296,200
+133% +$12.4M
TNDM icon
4
Tandem Diabetes Care
TNDM
$1.23B
$20.4M 3.04%
341,714
-91,101
-21% -$5.62M
FOLD
5
DELISTED
Amicus Therapeutics
FOLD
$20.1M 2.99%
2,059,961
-1,381,961
-40% -$12.7M
BMRN icon
6
BioMarin Pharmaceuticals
BMRN
$11.5B
$18.9M 2.82%
223,901
+82,100
+58% +$6.2M
AERI
7
DELISTED
Aerie Pharmaceuticals
AERI
$18.1M 2.7%
748,597
-342,937
-31% -$7.1M
EVH icon
8
Evolent Health
EVH
$661M
$18.1M 2.7%
1,999,172
+413,420
+26% +$3.36M
ATRC icon
9
AtriCure
ATRC
$1.78B
$17.4M 2.59%
533,756
+86,301
+19% +$2.46M
RETA
10
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$16.5M 2.46%
+80,650
New +$14.7M
PTCT icon
11
PTC Therapeutics
PTCT
$6.49B
$15.8M 2.36%
328,738
-48,500
-13% -$2.06M
KYNB
12
Kyntra Bio
KYNB
$29M
$15.7M 2.35%
14,672
+1,334
+10% +$1.36M
COLL icon
13
Collegium Pharmaceutical
COLL
$1.16B
$15.6M 2.33%
757,847
-147,400
-16% -$2.46M
INSP icon
14
Inspire Medical Systems
INSP
$1.51B
$15.2M 2.27%
205,000
-58,100
-22% -$3.73M
RCM
15
DELISTED
R1 RCM Inc. Common Stock
RCM
$15M 2.24%
1,159,073
+169,501
+17% +$1.94M
IMMU
16
DELISTED
Immunomedics Inc
IMMU
$14.6M 2.19%
692,123
-217,699
-24% -$3.84M
PTLA
17
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$14.5M 2.16%
606,189
+59,700
+11% +$1.65M
ASMB icon
18
Assembly Biosciences
ASMB
$503M
$14.2M 2.11%
57,725
-2,266
-4% -$417K
BMY icon
19
Bristol-Myers Squibb
BMY
$123B
$14.1M 2.1%
219,474
-61,123
-22% -$3.5M
APLS
20
DELISTED
Apellis Pharmaceuticals
APLS
$13.9M 2.08%
455,393
-541,590
-54% -$15M
HRC
21
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$13.9M 2.08%
122,599
+34,500
+39% +$3.64M
GBT
22
DELISTED
Global Blood Therapeutics, Inc.
GBT
$13.9M 2.07%
174,594
-66,446
-28% -$3.94M
VCRA
23
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$12.2M 1.81%
585,528
+106,800
+22% +$2.34M
TFX icon
24
Teleflex
TFX
$5.94B
$10.9M 1.63%
+29,057
New +$10M
STML
25
DELISTED
Stemline Therapeutics, Inc.
STML
$10.9M 1.62%
1,023,159
+345,400
+51% +$3.43M
1
2 3 4

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
CCM
Chicago Capital Management Chicago, Illinois $121M AUM 74.36% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
FWA
Fulcrum Wealth Advisors Bellevue, Washington $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM

Sectoral Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Sectoral Asset Management held 80 positions worth $670M, up 16% from $580M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Sectoral Asset Management withdrew a net $42.2M in Q4 2019, closing 15 positions and reducing 32 holdings. Its most notable exit was Wright Medical Group Inc, an estimated $21.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, down from 84% a quarter earlier, followed by Industrials and Technology.

Against the trend, Sectoral Asset Management opened a new position in Aprea Therapeutics worth $67.5M.

  • Sectoral Asset Management's largest Q4 2019 buy was Aprea Therapeutics: 73,517 shares worth $67.5M.
  • Sectoral Asset Management added most to Boston Scientific in Q4 2019, an estimated $12.4M increase.
  • Sectoral Asset Management's biggest Q4 2019 reduction was Teladoc Health, cutting an estimated $17.3M.
  • Sectoral Asset Management fully exited Wright Medical Group Inc in Q4 2019, selling an estimated $21.9M.
  • Sectoral Asset Management's ten largest holdings make up 37% of its $670M portfolio in Q4 2019.
  • Sectoral Asset Management opened 17 new positions and closed 15 in Q4 2019.
  • Sectoral Asset Management's portfolio value rose 16% quarter-over-quarter to $670M.

Based on Sectoral Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.